Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-25 @ 7:45 PM
Study NCT ID:
NCT04072835
Status:
COMPLETED
Last Update Posted:
2024-05-23
First Post:
2019-08-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
Sponsor:
Milestone Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-26
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-15
First Submit QC Date:
None
Study First Post Date:
2019-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-01-10
Results First Submit QC Date:
None
Results First Post Date:
2024-05-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-22
Last Update Post Date:
2024-05-23
Last Update Post Date Type:
ACTUAL